Krzysztof Bielawski

professor

Medical University of Białystok

Poland

Research Interests

Explore related searches

Professors in Poland Professors in Cancer Biology Cancer Biology professors in Poland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Krzysztof Bielawski is a faculty member at the Medical University of Białystok in Poland. His research focuses on the development of novel anticancer agents, with recent publications highlighting the apoptotic effects of various compounds in breast and colorectal cancer cells. He is particularly interested in the therapeutic potential of edible mushrooms and drug candidates for triple-negative breast cancer.

Articles (19)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (23)

Anna Galicka

Medical University of Białystok

POLAND

Krzysztof Bielawski

Research Interests

Explore related searches

Contact this professor

About

Articles (19)

5-Ene-2-arylaminothiazol-4(5H)-ones Induce Apoptosis in Breast Cancer Cells

Juglone-Bearing Thiopyrano[2,3-d]thiazoles Induce Apoptosis in Colorectal Adenocarcinoma Cells

The Anticancer Potential of Edible Mushrooms: A Review of Selected Species from Roztocze, Poland

Short Communication: Novel Di- and Triselenoesters as Effective Therapeutic Agents Inhibiting Multidrug Resistance Proteins in Breast Cancer Cells

The Proapoptotic Action of Pyrrolidinedione–Thiazolidinone Hybrids towards Human Breast Carcinoma Cells Does Not Depend on Their Genotype

Di- and Triselenoesters—Promising Drug Candidates for the Future Therapy of Triple-Negative Breast Cancer

Trastuzumab Potentiates Antitumor Activity of Thiopyrano[2,3-<i>d</i>]Thiazole Derivative in AGS Gastric Cancer Cells

Multi-Targeting Anticancer Activity of a New 4-Thiazolidinone Derivative with Anti-HER2 Antibodies in Human AGS Gastric Cancer Cells

Synthesis, Biological Activity, ADME and Molecular Docking Studies of Novel Ursolic Acid Derivatives as Potent Anticancer Agents

Tamoxifen Modulates the Immune Landscape of the Tumour Microenvironment: The Paired Siglec-5/14 Checkpoint in Anti-Tumour Immunity in an In Vitro Model of Breast Cancer

Assessment of an Anticancer Effect of the Simultaneous Administration of MM-129 and Indoximod in the Colorectal Cancer Model

Evaluation of Oromucosal Natural Gum-Based Emulgels as Novel Strategy for Photodynamic Therapy of Oral Premalignant Lesions

LC-PDA-MS and GC-MS Analysis of Scorzonera hispanica Seeds and Their Effects on Human Breast Cancer Cell Lines

p-Coumaric acid, Kaempferol, Astragalin and Tiliroside Influence the Expression of Glycoforms in AGS Gastric Cancer Cells

2-{5-[(<i>Z</i>,2<i>Z</i>)-2-Chloro-3-(4-nitrophenyl)-2-propenylidene]-4-oxo-2-thioxothiazolidin-3-yl}-3-methylbutanoic Acid as a Potential Anti-Breast Cancer Molecule

Mucin 1 as a Molecular Target of a Novel Diisoquinoline Derivative Combined with Anti-MUC1 Antibody in AGS Gastric Cancer Cells

Autophagy Modulators in Cancer Therapy

Mechanism of Anticancer Action of Novel Imidazole Platinum(II) Complex Conjugated with G2 PAMAM-OH Dendrimer in Breast Cancer Cells

DNA topoisomerases as molecular targets for anticancer drugs

Collaborators (23)

Anna Galicka

Magdalena Sulewska

Jadwiga Handzlik

Anna Basa

Marcin Cybulski

Adolfo Rivero-Müller

Olga Michalak

Mariusz Mojzych

Piotr Krzeczyński

Roman Lesyk

Monika Wujec

Iwona Radziejewska

Arkadiusz Surażynski

Przemyslaw Wielgat

Wojciech Miltyk

Andrzej Gzella

Justyna Hermanowicz

Dariusz Pawlak

Marlena Tynecka

Bartosz Trzaskowski

Natalia Wawrusiewicz-Kurylonek

Alicja Przybyszewska-Podstawka

Katarzyna Winnicka

Make your next move.